BioSpace News Archive

For the 2017 fourth quarter, the company reported net sales of $22.2 million, up 25.2 percent from $17.7 million in the prior-year period.

CryoLife announced today that 2017 fourth quarter and year-end financial results will be released on Wednesday, March 7, 2018 after the market closes.

ASIT Biotech today announces its annual results for the year 2017, prepared in accordance with the IFRS standards adopted by the European Union, as well as its recent clinical developments and 2018 outlook.

In memory of Ben and Beverly Horowitz, longtime chief executive officer and first lady of City of Hope, their family has donated $1 million to City of Hope to help advance groundbreaking CAR T cell immunotherapy research to combat cancer.

Held in Orlando, Florida, Feb. 12-15, the summit brings together 13 conferences under the SCOPE umbrella, creating an opportunity for idea sharing and cross-pollination among more than 1,400 clinical and R&D professionals.

First post-merger quarter to turn the corner and demonstrate growth.

The Series A warrants were issued as part of the units in Oncobiologics’ May 2016 initial public offering and are exercisable for shares of its common stock at an exercise price of $6.60 per share.

The Company filed a Form 8-K on February 7, 2018, which describes the improved deal terms.

Science Exchange will provide entrepreneurs and startups participating in the Venture Catalyst Smart Toolkit for Accelerated Research Translation Program immediate access to the private R&D marketplace with dedicated PhD-level sourcing support around the clock and a special contracting structure to accelerate their research and development projects.

Invitae today announced financial and operating results for the fourth quarter and full year ended December 31, 2017.